Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2795039 inhibits reactive oxygen species (ROS) production and NADPH consumption. GSK2795039 decreases apoptosis. GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) (pIC50: 6 in different cell-free assays).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 67.00 | |
2 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 163.00 | |
10 mg | In stock | $ 255.00 | |
25 mg | In stock | $ 452.00 | |
50 mg | In stock | $ 657.00 | |
100 mg | In stock | $ 935.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 178.00 |
Description | GSK2795039 inhibits reactive oxygen species (ROS) production and NADPH consumption. GSK2795039 decreases apoptosis. GSK2795039 is an inhibitor of NADPH oxidase 2 (NOX2) (pIC50: 6 in different cell-free assays). |
In vitro | GSK2795039 (25 μM; 24 hours) decreases the combinatory effect of FeSO4 and LPS-increased levels of apoptosis. It also reduced the presence of caspase-3-positive PC12 cells[2]. |
In vivo | GSK2795039 (intraperitoneal injection; 100 mg/kg; 1 hour before) reduces activity in a murine model of acute pancreatitis. It also decreases the levels of serum amylase triggered by systemic injection of cerulein[1]. |
Molecular Weight | 450.56 |
Formula | C23H26N6O2S |
CAS No. | 1415925-18-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 31 mg/mL(68.8 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2795039 1415925-18-6 Apoptosis Immunology/Inflammation Metabolism NF-Κb Reactive Oxygen Species NADPH ROS Inhibitor NADPH Oxidase NOX inhibit GSK-2795039 GSK 2795039 inhibitor